Understand your Tumour Grade and Ki-67

Grade describes how the cells look and behave under the microscope. Stage describes how far the cancer has travelled. They are measured differently, and they do not move together. An early-stage cancer can be grade 3. A later-stage one can be grade 1. Your oncologist reads them alongside the receptor result and your general health rather than reacting to either in isolation. If your report gives you both, they are answering two different questions and neither is the whole picture on its own.

The lab scores three things. How much the cells still form tubes. How alike they look. And how many were caught dividing. Each gets its own score, the three are added into a single total, and the total decides whether the grade is 1, 2 or 3. It is arithmetic applied to defined features rather than one person's impression, which is worth knowing because it makes the number reproducible. Ask your oncologist which of the three drove your total if you want to understand it further.

Ki-67 measures what proportion of cells were dividing at the instant your sample was taken. It is a snapshot rather than a rate, which is why it should not be read as how fast the cancer will grow. This matters: labs do not agree on where low ends and high begins. A number that looks frightening against something you read online may be perfectly ordinary against the scale your lab uses. Ask your oncologist how your specific result was interpreted rather than comparing it to a figure from a search result.

A higher grade does indicate a faster-behaving cancer. But treatments that act on dividing cells have more to act on when more cells are dividing. So a faster-growing cancer is not automatically the harder one to treat. Grade is also only one input among several, weighed alongside the stage, the receptor status and your general health. It is a real factor and worth understanding. But it is not the line that decides everything, and reading it on its own causes a great deal of unnecessary fear.

The grade describes the tissue that was examined. If a small needle sample was taken first, and more tissue is removed at surgery, the lab may look again at the larger piece. The grade can move. That is a change in the accuracy of the information rather than a change in the cancer. It is the same principle as a stage being confirmed after surgery. If your grade has changed between reports, ask whether the plan changes with it, because often it does not.

Grade feeds into the discussion, particularly around whether treatment that acts on dividing cells is worth adding. But the receptor result usually has more influence on which treatments are suitable, and the stage shapes the overall approach. Two people with the same grade can be given quite different plans because everything else about their reports differs. If you want to understand your own plan, ask which factor was the deciding one in your case rather than assuming it was the grade.